Cancer

New Advances in Skin Cancer Detection

New biomarkers to improve skin cancer detection and avoid delays in treatment are being developed by researchers in Australia.

Cancer

Thermo Fisher Scientific, AstraZeneca to Develop Solid Tissue and Blood-Based CDx Test for Tagrisso

Thermo Fisher Scientific is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic test for Tagrisso.

Cancer

Micronoma Gets Breakthrough Device Designation for Liquid Biopsy Assay that Detects Lung Carcinoma

Micronoma announced its OncobiotaLUNG assay received the Breakthrough Device Designation from the U.S. FDA for lung carcinoma detection.

Datar Blood Test for Brain Tumor Diagnosis Gets Breakthrough Device Designation

Jan 3, 2023 | Unknown Origin & Other Cancer Types

The FDA granted Datar Cancer Genetics Breakthrough Device Designation for its TriNetra-Glio test, a liquid biopsy to diagnose brain tumors.

Burning Rock’s Multi-Cancer Detection Blood Test Gets FDA Breakthrough Device Designation

Jan 3, 2023 | Cancer, Diagnostic Technologies

Burning Rock announced that its OverC Multi-Cancer Detection Blood Test has been granted Breakthrough Device Designation by the FDA.

Guardant Health Announces Results from Blood Test Study for Colorectal Cancer Detection

Jan 2, 2023 | Colorectal

Guardant Health unveiled results from a 20,000 patient study evaluating the performance of its blood test for detecting colorectal cancer.

Alercell Launching Leukemia Diagnostic Test

Dec 30, 2022 | Leukemia

Alercell is launching a leukemia diagnostic test based on sequencing DNA that will detect up to 51 Genes mutations in Leukemia patients.

DNA Testing Could Unlock Cancer’s Ancestral Roots

Dec 28, 2022 | Cancer, Molecular Diagnostic Analyzers

Researchers are revealing connections between cancer and race or ethnicity with software that infers ancestral roots in tumor DNA and RNA.

Advance in Genetic Testing Delivers Accurate Prediction of Disease

Dec 23, 2022 | Cancer, Sequencing Systems

Researchers have made an advancement in genetic testing that allows for more accurate prediction of individual’s increased cancer risk.

Data Analysis Finds 50 New Genes Related to Colorectal Cancer

Dec 21, 2022 | Colorectal

An analysis of more than 100,000 colorectal cancer cases uncovered hundreds of signals that may serve as new prevention targets.

Bluestar Genomics Commercializes Pancreatic Cancer Test

Dec 21, 2022 | Pancreatic

Bluestar Genomics has announced its U.S. and international commercialization of a test for early detection of pancreatic cancer.

Biomarker Project to Identify Cancer Predisposition in NF1 Patients

Dec 21, 2022 | Cancer

The Children’s Tumor Foundation will conduct a study to see if DNA-based blood tests offer a better understanding of cancer in NF1 patients.

Newly Discovered Genetic Risk Factors for Colorectal Cancer Help Screen for the Disease, Study Shows

Dec 20, 2022 | Colorectal

The new findings could help clinicians better determine who’s at the highest risk for colorectal cancer so they can receive early screening.

New Biomarker Strategy Devised to Screen & Diagnose Deadly Heart Complication from Cancer Treatment

Dec 20, 2022 | Cancer, Cardiovascular

Researchers devised a new biomarker-based strategy to screen for a deadly complication caused by monoclonal antibodies used to treat cancer.

Point-of-Care Program Increases Prostate Cancer Genetic Testing

Dec 15, 2022 | Prostate

Researchers pioneered and implemented a novel algorithm to provide genetic testing to patients with newly diagnosed prostate cancer.

Galen Prostate Cancer Diagnostic Solution Deployed at UPMC

Dec 15, 2022 | Analytical Software Systems, Prostate

Ibex Medical Analytics announced the live deployment by the University of Pittsburgh Medical Center (UPMC) of Galen Prostate.

FDA Approves Agilent’s NSCLC Liquid Biopsy Companion Diagnostic Test

Dec 14, 2022 | Lung Cancer

Agilent Technologies announced that the FDA has approved the ctDx FIRST as a companion diagnostic to identify advanced NSCLC.

New Prediction Algorithm Could Help Target Risk of Developing Prostate Cancer

Dec 13, 2022 | Prostate

Cambridge scientists have created a comprehensive tool for predicting an individual’s risk of developing prostate cancer.

Category: Cancer

Cancer

Cancer

Cancer